Co-Diagnostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Co-Diagnostics and other ETFs, options, and stocks.About CODX
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
CEODwight Howard Egan
CEODwight Howard Egan
Employees132
Employees132
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2013
Founded2013
Employees132
Employees132
CODX Key Statistics
Market cap23.80M
Market cap23.80M
Price-Earnings ratio-0.40
Price-Earnings ratio-0.40
Dividend yield—
Dividend yield—
Average volume1.57M
Average volume1.57M
High today$0.4063
High today$0.4063
Low today$0.3416
Low today$0.3416
Open price$0.3606
Open price$0.3606
Volume2.47M
Volume2.47M
52 Week high$1.55
52 Week high$1.55
52 Week low$0.2275
52 Week low$0.2275
Stock Snapshot
As of today, Co-Diagnostics(CODX) shares are valued at $0.38. The company's market cap stands at 23.8M, with a P/E ratio of -0.40.
On 2025-12-05, Co-Diagnostics(CODX) stock traded between a low of $0.34 and a high of $0.41. Shares are currently priced at $0.38, which is +11.3% above the low and -6.4% below the high.
The Co-Diagnostics(CODX)'s current trading volume is 2.47M, compared to an average daily volume of 1.57M.
During the past year, Co-Diagnostics(CODX) stock moved between $0.23 at its lowest and $1.55 at its peak.
During the past year, Co-Diagnostics(CODX) stock moved between $0.23 at its lowest and $1.55 at its peak.
People also own
Based on the portfolios of people who own CODX. This list is generated using Robinhood data, and it’s not a recommendation.